108 related articles for article (PubMed ID: 25251331)
1. Immunosuppressive therapies after intestinal transplant modulate the expression of Th1 signature genes during acute cellular rejection. Implications in the search for rejection biomarkers.
Zambernardi A; Chiodetti A; Meier D; Cabanne A; Nachman F; Solar H; Rumbo C; Gondolesi GE; Rumbo M
Clin Transplant; 2014 Dec; 28(12):1365-71. PubMed ID: 25251331
[TBL] [Abstract][Full Text] [Related]
2. Sequential histologic changes in the healing process in small bowel allografts treated for acute cellular rejection.
Liu L; Fischer RT; Xu L; Talmon GA
Transplant Proc; 2013 Mar; 45(2):643-8. PubMed ID: 23267814
[TBL] [Abstract][Full Text] [Related]
3. Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies.
Asaoka T; Island ER; Tryphonopoulos P; Selvaggi G; Moon J; Tekin A; Amador A; Levi DM; Garcia J; Smith L; Nishida S; Weppler D; Tzakis AG; Ruiz P
Transpl Int; 2011 Jul; 24(7):697-707. PubMed ID: 21557779
[TBL] [Abstract][Full Text] [Related]
4. Potential predictive markers in protocol biopsies for premature renal graft loss.
Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
[TBL] [Abstract][Full Text] [Related]
5. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic osteoarthropathy in intestinal transplant recipients.
McGuire MM; Demehri S; Kim HB; Kamin D
J Pediatr Surg; 2010 Nov; 45(11):e19-22. PubMed ID: 21034923
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
8. Genetic expression profile during acute cellular rejection in clinical intestinal transplantation.
Bradley SP; Banner B; Elias G; Pahari MP; Brown M; Rastellini C; Cicalese L
Transplantation; 2008 Oct; 86(7):998-1001. PubMed ID: 18852668
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 8 -251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India.
Singh R; Kesarwani P; Ahirwar DK; Kapoor R; Mittal RD
Transpl Immunol; 2009 May; 21(1):13-7. PubMed ID: 19189859
[TBL] [Abstract][Full Text] [Related]
10. Immunological protection of small bowel by simultaneously transplanted liver graft in pigs.
Yin ZY; Li N; Wang XM; Ni XD; Jiang F; Li YS; Li JS
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):363-9. PubMed ID: 19666404
[TBL] [Abstract][Full Text] [Related]
11. Plasma citrulline after small bowel transplantation: effect of time from transplantation, acute cellular rejection, and renal failure.
Pironi L; Guidetti M; Lauro A; Zanfi C; Agostini F; D'Errico A; Altimari A; Pinna AD
Clin Transplant; 2015 Nov; 29(11):1039-46. PubMed ID: 26358637
[TBL] [Abstract][Full Text] [Related]
12. Donor-derived bone marrow transfusion produces mixed chimerism and promotes a Th2 shift in Th1/Th2 balance in rat heterotopic small bowel transplantation.
Hu A; Li Q; Shi H; Tai Q; Wu L; Xiong J; Fu B; He X
Dig Liver Dis; 2012 Dec; 44(12):988-94. PubMed ID: 22954489
[TBL] [Abstract][Full Text] [Related]
13. Effects of immunosuppressive therapy after experimental small bowel transplantation in rats.
Pech T; Fujishiro J; Finger T; von Websky M; Stoffels B; Wehner S; Abu-Elmagd K; Kalff JC; Schaefer N
Transpl Immunol; 2011 Sep; 25(2-3):112-8. PubMed ID: 21820512
[TBL] [Abstract][Full Text] [Related]
14. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients.
Masuda S; Goto M; Fukatsu S; Uesugi M; Ogura Y; Oike F; Kiuchi T; Takada Y; Tanaka K; Inui K
Clin Pharmacol Ther; 2006 Jan; 79(1):90-102. PubMed ID: 16413244
[TBL] [Abstract][Full Text] [Related]
15. Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.
Vianna R
Minerva Pediatr; 2009 Jun; 61(3):293-303. PubMed ID: 19461573
[TBL] [Abstract][Full Text] [Related]
16. Intestinal and multivisceral transplantation immunosuppression protocols--literature review.
Trevizol AP; David AI; Dias ER; Mantovani D; Pécora R; D'Albuquerque LA
Transplant Proc; 2012 Oct; 44(8):2445-8. PubMed ID: 23026616
[TBL] [Abstract][Full Text] [Related]
17. Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation.
Asaoka T; Marubashi S; Kobayashi S; Hama N; Eguchi H; Takeda Y; Tanemura M; Wada H; Takemasa I; Takahashi H; Ruiz P; Doki Y; Mori M; Nagano H
J Surg Res; 2012 Dec; 178(2):1003-14. PubMed ID: 22889476
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin A4 attenuates acute rejection via shifting TH1/TH2 cytokine balance in rat liver transplantation.
Liao W; Zeng F; Kang K; Qi Y; Yao L; Yang H; Ling L; Wu N; Wu D
Transplant Proc; 2013; 45(6):2451-4. PubMed ID: 23742835
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.
Touzot M; Couvrat-Desvergnes G; Castagnet S; Cesbron A; Renaudin K; Cantarovich D; Giral M
Transplantation; 2015 Jan; 99(1):63-8. PubMed ID: 25029384
[TBL] [Abstract][Full Text] [Related]
20. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome.
Rodríguez-Perálvarez M; Germani G; Papastergiou V; Tsochatzis E; Thalassinos E; Luong TV; Rolando N; Dhillon AP; Patch D; O'Beirne J; Thorburn D; Burroughs AK
J Hepatol; 2013 Feb; 58(2):262-70. PubMed ID: 23023010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
